Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers
- Language: English
- 101 Pages
- Published: October 2012
The analysts forecast the Global Minimally Invasive VCF Devices market to grow at a CAGR of 10.12 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of osteoporosis. The Global Minimally Invasive VCF Devices market has also been witnessing an increased focus on reduced risk of cement leakage by vendors. However, the high cost of VCF surgeries could pose a challenge to the growth of this market.
The report, Global Minimally Invasive VCF Devices Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Minimally Invasive VCF Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Medtronic Inc., Stryker Corp., Carefusion Corp., De Puy Spine Inc., and Zimmer Holdings Inc.
The other vendors mentioned in the report are Alphatec Spine Inc., AOI Medical Inc., Benvenue Medical Inc., Biomet Inc., Bonesupport AB, Cook Medical Inc., Crosstrees Medical Inc.
Key questions answered in this report:
- What will the market size be in 2016 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of these key vendors?
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
The report is also available as part of our annual subscription offer. Please get in touch with our customer service team in order to find out more. SHOW LESS READ MORE >
01. Executive Summary
02. Scope of the Report
02.1 Market Overview
02.2 Product Offerings
03. Market Research Methodology
03.1 Market Research Process
03.2 Research Design
03.3 Research Methodology
04. List of Abbreviations
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Technology
07.1 Global Minimally Invasive VCF Devices Market by Technology 2012-2016
07.2 Global Vertebroplasty Market
07.2.1 Market Size and Forecast
07.2.2 Global Vertebroplasty Market by Number of Procedures
07.3 Global Kyphoplasty Market
07.3.1 Market Size and Forecast
07.3.2 Global Kyphoplasty Market by Number of Procedures
07.4 Global Minimally Invasive VCF Devices Market Segmentation by Technology 2012-2016
08. Complications Associated with Vertebroplasty and Kyphoplasty
09. Geographical Segmentation
09.1 Global Minimally Invasive VCF Devices Market by Geographical Segmentation
09.2 Global Vertebroplasty Market by Geographical Segmentation
09.3 Global Kyphoplasty Market by Geographical Segmentation
10. Key Leading Countries
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2012
18.3 Other Prominent Vendors
18.3.1 Product Portfolio Matrix
19. Key Vendor Analysis
19.1 Medtronic Inc.
19.1.1 Business Overview
19.1.2 Business Segmentation
19.1.3 Key Information
19.1.4 SWOT Analysis
19.2 Stryker Corp.
19.2.1 Business Overview
19.2.2 Business Segmentation
19.2.3 Key Information
19.2.4 SWOT Analysis
19.3 DePuy Spine Inc.
19.3.1 Business Overview
19.3.2 Business Segmentation
19.3.3 Key Information
19.3.4 SWOT Analysis
19.4 Zimmer Holdings Inc.
19.4.1 Business Overview
19.4.2 Business Segmentation
19.4.3 Key Information
19.4.4 SWOT Analysis
19.5 CareFusion Corp.
19.5.1 Business Overview
19.5.2 Business Segmentation
19.5.3 Key Information
19.5.4 SWOT Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Minimally Invasive VCF Devices Market Segmentation
Exhibit 3: Categorization of Global Spine Surgery Devices Market 2011
Exhibit 4: Global Spine Surgery Devices Market by Category Segmentation 2012
Exhibit 5: Global Minimally Invasive VCF Devices Market 2012-2016 (US$ million)
Exhibit 6: Global Minimally Invasive VCF Devices Market Segmentation by Technology
Exhibit 7: Global Minimally Invasive VCF Devices Market Segmentation by Technology 2012
Exhibit 8: Global Vertebroplasty Market 2012-2016 (US$ million)
Exhibit 9: Number of Vertebroplasty Procedures 2012-2016
Exhibit 10: Global Kyphoplasty Market 2012-2016 (US$ million)
Exhibit 11: Number of Kyphoplasty Procedures 2012-2016
Exhibit 12: Global Minimally Invasive VCF Devices Market Segmentation by Technology 2012-2016 (in percentage)
Exhibit 13: Complication Rates of Vertebroplasty and Kyphoplasty
Exhibit 14: Global Minimally Invasive VCF Devices Market by Geographical Segmentation 2012
Exhibit 15: Global Vertebroplasty Market by Geographical Segmentation 2012
Exhibit 16: Global Kyphoplasty Market by Geographical Segmentation 2012
Exhibit 17: Business Segmentation of CareFusion Corp.
Exhibit 18: Business Segments of DePuy Spine Inc.
Exhibit 19: Business Segmentation of Stryker Corp.
Exhibit 20: Business Segments of Zimmer Holdings Inc.
Commenting on the report, an analyst from the team said: “Companies are also focusing on reducing the risks associated with the VCF treatments during and after surgery. Thus, they are coming up with advanced equipment which reduces the risk of cement leakage during surgery. Further, as a result of the latest innovations in VCF products, the risk in the vertebroplasty procedure is getting reduced. Furthermore, the quality of the balloons introduced during the kyphoplasty procedure is also being improved so as to reduce the leakage of the cement inserted inside them during the surgery.”
According to the report, one of the major growth factors driving the Global Minimally Invasive VCF Devices market is the increasing incidence of osteoporosis. About 85 percent of the VCF cases are due to osteoporosis.
Further, the report states that , most VCF treatments are expensive for patients in developing nations. Kyphoplasty treatments are much more expensive than vertebroplasty treatments, which could affect the future growth of the Global Minimally Invasive VCF Devices market. Moreover, the high price of these treatments is also due to the monopolistic approach in this market, where Medtronic has acquired almost 80-82 percent of the market share. Hence, this market lacks competitive pricing.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
- Alphatec Spine Inc.
- AOI Medical Inc.
- Benvenue Medical Inc.
- Biomet Inc.
- Bonesupport AB
- Carefusion Corp.
- Cook Medical Inc.
- Crosstrees Medical Inc.
- De Puy Spine Inc.
- Medtronic Inc.
- Stryker Corp.
- Zimmer Holdings Inc.